(FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | (Q6)Sep 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -18.10%97.28M | -24.68%47.21M | -20.25%118.77M | -34.70%62.68M | -33.42%148.94M | -17.24%95.99M | -47.43%223.68M | -65.67%115.99M | -75.23%425.5M | -59.73%337.88M |
Operating income | -18.10%97.28M | -24.68%47.21M | -20.25%118.77M | -34.70%62.68M | -33.42%148.94M | -17.24%95.99M | -47.43%223.68M | -65.67%115.99M | -75.23%425.5M | -59.73%337.88M |
Cost of sales | 7.31%-26.5M | 8.47%-14.97M | 27.55%-28.59M | 45.16%-16.35M | 41.74%-39.47M | 27.98%-29.82M | 75.88%-67.74M | 83.48%-41.4M | 81.70%-280.8M | 65.89%-250.68M |
Operating expenses | 7.31%-26.5M | 8.47%-14.97M | 27.55%-28.59M | 45.16%-16.35M | 41.74%-39.47M | 27.98%-29.82M | 75.88%-67.74M | 83.48%-41.4M | 81.70%-280.8M | 65.89%-250.68M |
Gross profit | -21.51%70.78M | -30.40%32.25M | -17.62%90.18M | -29.99%46.33M | -29.80%109.47M | -11.27%66.18M | 7.77%155.94M | -14.47%74.58M | -21.21%144.7M | -16.41%87.2M |
Selling expenses | 6.26%-9.75M | ---- | ---10.4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Administrative expenses | 27.20%-53.21M | ---- | ---73.09M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Profit from asset sales | ---- | ---- | ---96.91M | ---92.75M | ---- | ---- | --15.87M | --5.2M | ---- | ---- |
Revaluation surplus | -117.21%-266.14M | -243.14%-82.38M | -28.10%-122.53M | -170.11%-24.01M | -272.39%-95.65M | -2.52%34.24M | -63.32%55.49M | -30.66%35.13M | -32.63%151.28M | -67.30%50.66M |
-Changes in the fair value of investment property | -117.21%-266.14M | -243.14%-82.38M | -28.10%-122.53M | -170.11%-24.01M | -286.01%-95.65M | 6.88%34.24M | -64.92%51.42M | -36.76%32.04M | -34.72%146.59M | -67.30%50.66M |
-Changes in the fair value of derivative financial instruments | ---- | ---- | ---- | ---- | ---- | ---- | -13.42%4.06M | --3.09M | --4.69M | ---- |
Impairment and provision | -9.59%-64.46M | -109.78%-10.88M | -240.39%-58.82M | 5.66%-5.18M | -193.68%-17.28M | -5,487.25%-5.5M | 73.30%-5.88M | 101.41%102K | 36.44%-22.04M | -37.68%-7.25M |
-Goodwill impairment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -50.75%-15.32M | -25.93%-6.89M |
-Other impairment is provision | -9.59%-64.46M | -109.78%-10.88M | -240.39%-58.82M | 5.66%-5.18M | -193.68%-17.28M | -5,487.25%-5.5M | 12.48%-5.88M | 128.57%102K | 72.58%-6.72M | -271.63%-357K |
Special items of operating profit | 21.49%72.94M | -15.32%61.26M | 41.15%60.03M | 803,677.78%72.34M | 342.53%42.53M | -99.97%9K | -225.52%-17.54M | 355.49%26.79M | 124.63%13.97M | 142.95%5.88M |
Operating profit | -18.11%-249.85M | 107.64%250K | -641.41%-211.53M | -103.45%-3.27M | -80.84%39.07M | -33.05%94.93M | -29.19%203.87M | 3.90%141.8M | -24.18%287.91M | -20.60%136.49M |
Financing cost | 6.70%-173.5M | 21.94%-88.49M | 35.52%-185.95M | 18.85%-113.36M | -15.36%-288.37M | -13.26%-139.7M | -5.81%-249.97M | -9.60%-123.35M | -18.53%-236.25M | -13.39%-112.55M |
Share of profits of associates | ---- | ---- | -83.03%1.16M | -88.02%1.16M | -29.35%6.84M | 152.23%9.69M | 935.72%9.68M | --3.84M | --935K | ---- |
Special items of earning before tax | ---- | 29.13%-32.44M | ---- | 17.88%-45.78M | 18.99%-89.35M | -7.88%-55.75M | 16.35%-110.3M | 16.79%-51.68M | -10.99%-131.86M | ---62.1M |
Earning before tax | -6.82%-423.35M | 25.16%-120.68M | -19.44%-396.32M | -77.53%-161.26M | -126.17%-331.81M | -209.12%-90.83M | -85.10%-146.71M | 23.01%-29.38M | -228.61%-79.26M | -152.53%-38.16M |
Tax | 111.79%38.22M | 194.61%13.23M | 28.78%18.05M | 152.98%4.49M | 190.60%14.01M | -1.47%-8.48M | 61.11%-15.47M | 55.93%-8.36M | 23.93%-39.77M | 40.41%-18.96M |
After-tax profit from continuing operations | -1.81%-385.13M | 31.46%-107.45M | -19.03%-378.28M | -57.85%-156.76M | -95.96%-317.8M | -163.15%-99.31M | -36.24%-162.18M | 33.93%-37.74M | -1,373.79%-119.04M | -239.90%-57.12M |
After-tax profit from non-continuing business | ---- | ---- | 50.47%-7.21M | ---13.92M | ---14.55M | ---- | ---- | ---- | -251.45%-11.83M | --8.45M |
Earning after tax | 0.09%-385.13M | 37.05%-107.45M | -15.99%-385.48M | -71.87%-170.68M | -104.93%-332.35M | -163.15%-99.31M | -23.93%-162.18M | 22.46%-37.74M | -862.80%-130.87M | -219.20%-48.67M |
Minority shareholders should account for profits from continuing business | -102.18%-3.34M | 80.48%-1.71M | -295.62%-1.65M | ---8.75M | --845K | ---- | ---- | ---- | 102.49%116K | --190K |
Minority shareholders should account for non-continuing business profits | ---- | ---- | -696.78%-5.19M | ---2K | --869K | ---- | ---- | ---- | -131.48%-922K | --3.31M |
Minority profit | 51.13%-3.34M | 80.49%-1.71M | -499.01%-6.84M | -298.26%-8.75M | -89.72%1.71M | -39.19%4.41M | 2,168.73%16.67M | 107.52%7.26M | 53.44%-806K | 115.73%3.5M |
Shareholders should account for profits from continuing business | -1.37%-381.78M | 28.56%-105.74M | -18.19%-376.62M | ---148.02M | ---318.65M | ---- | ---- | ---- | -950.78%-119.15M | ---57.31M |
Shareholders should account for profits from non-continuing business | ---- | ---- | 86.90%-2.02M | ---13.92M | ---15.42M | ---- | ---- | ---- | -323.43%-10.91M | --5.14M |
Profit attributable to shareholders | -0.83%-381.78M | 34.70%-105.74M | -13.34%-378.64M | -56.12%-161.93M | -86.78%-334.06M | -130.51%-103.72M | -37.52%-178.85M | 13.75%-45M | -788.62%-130.06M | -233.05%-52.17M |
Basic earnings per share | -0.83%-0.3265 | 34.73%-0.0904 | -13.34%-0.3238 | -56.14%-0.1385 | 50.62%-0.2857 | 42.37%-0.0887 | -30.05%-0.5786 | -331.09%-0.1539 | -3,323.91%-0.4449 | -215.53%-0.0357 |
Diluted earnings per share | -0.83%-0.3265 | 34.73%-0.0904 | -13.34%-0.3238 | -56.14%-0.1385 | 50.62%-0.2857 | 42.37%-0.0887 | -30.05%-0.5786 | -331.09%-0.1539 | -3,323.91%-0.4449 | -215.53%-0.0357 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | -- | National Health Certified Public Accountants Limited | -- | National Health Certified Public Accountants Limited | -- | National Health Certified Public Accountants Limited | -- | National Health Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data